FORTIS - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 2.9
| Stock Code | FORTIS | Market Cap | 72,695 Cr. | Current Price | 963 ₹ | High / Low | 1,105 ₹ |
| Stock P/E | 357 | Book Value | 122 ₹ | Dividend Yield | 0.10 % | ROCE | 3.96 % |
| ROE | 2.23 % | Face Value | 10.0 ₹ | DMA 50 | 943 ₹ | DMA 200 | 895 ₹ |
| Chg in FII Hold | -1.86 % | Chg in DII Hold | 2.02 % | PAT Qtr | 33.0 Cr. | PAT Prev Qtr | 24.7 Cr. |
| RSI | 51.8 | MACD | 7.23 | Volume | 12,63,181 | Avg Vol 1Wk | 16,65,642 |
| Low price | 741 ₹ | High price | 1,105 ₹ | PEG Ratio | 6.42 | Debt to equity | 0.23 |
| 52w Index | 60.9 % | Qtr Profit Var | 382 % | EPS | 3.05 ₹ | Industry PE | 46.3 |
📊 FORTIS shows weak fundamentals for long-term investment at current valuations. The stock trades at an extremely high P/E (357 vs industry average 46.3), with modest ROE (2.23%) and ROCE (3.96%). EPS of 3.05 ₹ is very low relative to price, and dividend yield is negligible at 0.10%. The PEG ratio of 6.42 suggests poor growth-adjusted valuation. Debt-to-equity is manageable at 0.23, but overall profitability metrics remain weak despite recent PAT improvement.
💡 Ideal Entry Price Zone: Current price is 963 ₹, with DMA 50 at 943 ₹ and DMA 200 at 895 ₹. A safer entry zone would be between 880–920 ₹, closer to support levels, only if earnings improve significantly.
📈 Exit Strategy: For existing holders, caution is advised. Investors should consider reducing exposure on rallies near 980–1,000 ₹. Long-term holding is only justified if ROE and ROCE improve substantially, EPS grows consistently, and dividend payouts increase. Otherwise, a gradual exit is recommended.
🌟 Positive
- 📈 Quarterly PAT improved (33 Cr vs 24.7 Cr previous quarter).
- 📊 DII holdings increased (+2.02%), showing domestic institutional support.
- 📈 MACD at 7.23 indicates mild bullish momentum.
⚠️ Limitation
- 📉 Extremely high P/E (357) compared to industry average (46.3).
- 📊 Weak ROE (2.23%) and ROCE (3.96%), showing poor capital efficiency.
- 📉 PEG ratio (6.42) indicates poor growth-adjusted valuation.
- 💰 Dividend yield is negligible (0.10%), offering no income support.
📰 Company Negative News
- 📉 EPS remains very low at 3.05 ₹.
- 📊 FII holdings decreased (-1.86%), showing foreign investor caution.
- 📉 Trading volumes below weekly average, showing reduced short-term interest.
📰 Company Positive News
- 📈 Quarterly profit variation positive (382%).
- 📊 RSI at 51.8 indicates neutral momentum, not overbought.
🏭 Industry
- 📊 Industry PE is 46.3, much lower than company’s 357, highlighting extreme overvaluation.
- 📈 Healthcare and hospital sector growth supported by rising demand, though company-specific metrics lag peers.
✅ Conclusion
⚖️ FORTIS is currently overvalued with weak profitability metrics and negligible dividend support. It is not a strong candidate for long-term investment unless fundamentals improve significantly. Existing investors should consider exiting near 980–1,000 ₹ unless earnings recover and ROE/ROCE strengthen.
For deeper insights, you could explore a peer comparison or a valuation analysis to refine entry and exit strategies.